Undoubtedly, numerous bioactive constituents, phytochemicals, and extracts were validated for their health beneficial effects to alleviate complications of Triton-related hypercholesterolemia focusing entirely on hypocholesterolemia, however, ovarian tumours and reproductive disorders, the major risk factors of hypercholesterolemia, was ignored. So, the aim is elaborated to investigate the larva extract of housefly combined with Triton as a preliminary study. The female rats were induced intraperitoneally by 200 mg/kgbw Triton for hypercholesterolemia. The hypercholesterolemic females gave 200mg/kg larval extract orally for improvement activity. In addition to non-lipidemic control and extract-treated group (n = 10/30days). All lipid profile markers, total cholesterol 33.77%, triglycerides 24.95%, and low-density lipoprotein 46.34%, very low-density lipoprotein 59.73%, were significantly decreased in Triton with extract group except the levels of high-density lipoprotein were increased 25%. Besides, the larval extract significantly enhances the depleted ovarian catalase, superoxide dismutase, glutathione peroxidase, glutathione activities and lowers the malondialdehyde levels. The anti-inflammatory effect was enhanced by lowering xanthine oxidase and nitric oxide levels. A corresponding alleviation in ovarian cytotoxicity was noticed in the suppression of lactate dehydrogenase, α-amylase, and myeloperoxidase concentrations. Levels of maternal and embryo-fetal toxicities and fertility were improved in the group of the larval extract with Triton. Concisely, the extract of housefly larvae could attenuate the reproductive and ovarian disorders via retrieving the activities of associated parameters, and that extract can potentially be a promising candidate for human therapeutic development.